These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors]. Hashimoto N; Tsuboi A; Chiba Y; Izumoto S; Oka Y; Yoshimine T; Sugiyama H Brain Nerve; 2009 Jul; 61(7):805-14. PubMed ID: 19618858 [TBL] [Abstract][Full Text] [Related]
4. The contenders. Vaccines and viruses take aim at cancer cells. Clancy F Minn Med; 2005 Apr; 88(4):24-8. PubMed ID: 15940888 [No Abstract] [Full Text] [Related]
5. Immunotherapy in human glioblastoma. Szabo AT; Carpentier AF Rev Neurol (Paris); 2011 Oct; 167(10):668-72. PubMed ID: 21885075 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutic vaccination for glioblastoma]. Dietrich PY; Dutoit V Med Sci (Paris); 2020 Apr; 36(4):319-322. PubMed ID: 32356704 [No Abstract] [Full Text] [Related]
7. [Vaccine therapy for brain tumors using tumor cells genetically modified to express B7.1]. Kajiwara K; Morioka J; Yoshikawa K; Suzuki M Nihon Rinsho; 2005 Sep; 63 Suppl 9():578-81. PubMed ID: 16201584 [No Abstract] [Full Text] [Related]
8. [A trial of rabies vaccine treatment of patients with glioblastoma multiforme]. Filipov FV Zh Vopr Neirokhir Im N N Burdenko; 1988; (3):38-40. PubMed ID: 2842989 [TBL] [Abstract][Full Text] [Related]
9. Achieving graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy. Petrosiute A; Auletta JJ; Lazarus HM Immunotherapy; 2012 Nov; 4(11):1139-51. PubMed ID: 23194364 [TBL] [Abstract][Full Text] [Related]
11. Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients? Van Gool S; De Vleeschouwer S Expert Rev Neurother; 2012 Oct; 12(10):1173-6. PubMed ID: 23082731 [No Abstract] [Full Text] [Related]
12. Heat shock proteins in glioblastomas. Yang I; Fang S; Parsa AT Neurosurg Clin N Am; 2010 Jan; 21(1):111-23. PubMed ID: 19944971 [TBL] [Abstract][Full Text] [Related]
13. [II. Autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma]. Maruyama T; Muragaki Y; Ishikawa E; Nitta M; Saito T; Ohno T; Iseki H; Okada Y Gan To Kagaku Ryoho; 2015 Jun; 42(6):683-6. PubMed ID: 26242005 [No Abstract] [Full Text] [Related]
14. Toward a glioblastoma vaccine: promise and potential pitfalls. Fine HA J Clin Oncol; 2004 Nov; 22(21):4240-3. PubMed ID: 15452184 [No Abstract] [Full Text] [Related]
15. Vaccine-based immunotherapy for glioblastoma. Thomas AA; Fisher JL; Ernstoff MS; Fadul CE CNS Oncol; 2013 Jul; 2(4):331-49. PubMed ID: 25054578 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for glioma: promises and challenges. Han SJ; Zygourakis C; Lim M; Parsa AT Neurosurg Clin N Am; 2012 Jul; 23(3):357-70. PubMed ID: 22748649 [TBL] [Abstract][Full Text] [Related]
18. New weapons against brain tumors. Emerging techniques from multi-national research curb the growth of brain tumors. Duke Med Health News; 2007 Oct; 13(10):5. PubMed ID: 18277427 [No Abstract] [Full Text] [Related]
19. [Immunology and immunotherapy of cerebral tumors. Current status]. Trouillas P Rev Neurol (Paris); 1973 Jan; 128(1):23-38. PubMed ID: 4367367 [No Abstract] [Full Text] [Related]
20. Advances in Immunotherapy for Glioblastoma Multiforme. Huang B; Zhang H; Gu L; Ye B; Jian Z; Stary C; Xiong X J Immunol Res; 2017; 2017():3597613. PubMed ID: 28299344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]